|
US5554513A
(en)
|
1979-11-21 |
1996-09-10 |
Yeda Research & Development Co. Ltd. |
Production of recombinant human interferon-beta2
|
|
IL58765A
(en)
|
1979-11-21 |
1986-09-30 |
Yeda Res & Dev |
Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
|
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
|
US5670373A
(en)
|
1988-01-22 |
1997-09-23 |
Kishimoto; Tadamitsu |
Antibody to human interleukin-6 receptor
|
|
IL88375A
(en)
|
1988-11-14 |
1995-07-31 |
Yeda Res & Dev |
Monoclonal antibodies that specifically bind interferon-bia 2 natural and recombinant and a natural and recombinant interferon-beta 2 purification method and method
|
|
US5216128A
(en)
|
1989-06-01 |
1993-06-01 |
Yeda Research And Development Co., Ltd. |
IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it
|
|
DE69027121T3
(de)
|
1989-08-07 |
2001-08-30 |
Peptech Ltd., Dee Why |
Bindeligande für tumornekrosisfaktor
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US6657103B1
(en)
|
1990-01-12 |
2003-12-02 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0542810A1
(en)
|
1990-08-02 |
1993-05-26 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
|
ES2103770T3
(es)
|
1990-11-26 |
1997-10-01 |
Akzo Nobel Nv |
Procedimiento de produccion de anticuerpos monoclonales.
|
|
JPH06508821A
(ja)
|
1991-03-07 |
1994-10-06 |
セラジュン インク |
ウイルス病治療のための細胞表面受容体を標的とする分子の使用
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
EP0628639B1
(en)
|
1991-04-25 |
1999-06-23 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin 6 receptor
|
|
JPH05304986A
(ja)
|
1992-04-28 |
1993-11-19 |
Tosoh Corp |
ｇｐ１３０蛋白質に対するモノクロ−ナル抗体
|
|
JPH08503603A
(ja)
|
1992-08-21 |
1996-04-23 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ リプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
新規のｂリンパ腫細胞株および抗原
|
|
US5888511A
(en)
|
1993-02-26 |
1999-03-30 |
Advanced Biotherapy Concepts, Inc. |
Treatment of autoimmune diseases, including AIDS
|
|
US5856135A
(en)
|
1993-05-31 |
1999-01-05 |
Chugai Seiyaku Kabushiki Kaisha |
Reshaped human antibody to human interleukin-6
|
|
US5888510A
(en)
|
1993-07-21 |
1999-03-30 |
Chugai Seiyaku Kabushiki Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
|
FR2707882B1
(fr)
|
1993-07-23 |
1997-08-01 |
Immunotech Sa |
Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
|
|
NZ278607A
(en)
|
1994-02-07 |
1999-05-28 |
Knoll Ag |
Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above
|
|
US5882872A
(en)
|
1994-04-28 |
1999-03-16 |
Kudsk; Kenneth A. |
Use of an IL-6 assay for predicting the development of post-trauma complications
|
|
US5646005A
(en)
|
1994-04-28 |
1997-07-08 |
Kudsk; Kenneth A. |
Use of an IL-6 assay for predicting the development of post-trauma complications
|
|
US5707624A
(en)
|
1994-06-03 |
1998-01-13 |
The Regents Of The University Of Michigan |
Treatment of Kaposi's sarcoma by inhibition of scatter factor
|
|
EP0721783B1
(en)
|
1994-06-07 |
2005-03-16 |
Toray Industries, Inc. |
Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung
|
|
US5545623A
(en)
|
1994-06-10 |
1996-08-13 |
Akira Matsumori |
Method of inhibiting secretion of inflammatory cytokines
|
|
US8017121B2
(en)
|
1994-06-30 |
2011-09-13 |
Chugai Seiyaku Kabushika Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
|
CN1306963C
(zh)
|
1994-10-21 |
2007-03-28 |
岸本忠三 |
用于治疗il－6产生所致疾病的药物组合物
|
|
EP0800829B2
(en)
|
1994-12-29 |
2012-07-25 |
Chugai Seiyaku Kabushiki Kaisha |
Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin
|
|
ES2264135T3
(es)
|
1995-02-13 |
2006-12-16 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibidor de la descomposicion de proteinas musculares que contienen anticuerpos frente al receptor de il-6.
|
|
US6482927B1
(en)
|
1995-11-27 |
2002-11-19 |
Millennium Pharmaceuticals, Inc. |
Chimeric proteins comprising the extracellular domain of murine Ob receptor
|
|
EP0914416B1
(en)
|
1996-03-30 |
2002-06-12 |
Science Park Raf S.p.A. |
Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
|
|
US5854398A
(en)
|
1996-07-25 |
1998-12-29 |
The Trustees Of Columbia University In The City Of New York |
Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof
|
|
ATE218143T1
(de)
|
1996-09-03 |
2002-06-15 |
Gsf Forschungszentrum Umwelt |
Verwendung bi-und trispezifischer antikörper zur induktion einer tumorimmunität
|
|
AU736282B2
(en)
|
1997-03-21 |
2001-07-26 |
Chugai Seiyaku Kabushiki Kaisha |
A preventive or therapeutic agent for sensitized T cell- mediated diseases comprising IL-6 antagonist as an active ingredient
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
WO1998051329A1
(en)
|
1997-05-15 |
1998-11-19 |
Chugai Seiyaku Kabushiki Kaisha |
Cachexia remedy
|
|
DE19725586C2
(de)
|
1997-06-17 |
1999-06-24 |
Gsf Forschungszentrum Umwelt |
Verfahren zur Herstellung von Zellpräparaten zur Immunisierung mittels heterologer intakter bispezifischer und/oder trispezifischer Antikörper
|
|
US20020187150A1
(en)
|
1997-08-15 |
2002-12-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient
|
|
US6407218B1
(en)
|
1997-11-10 |
2002-06-18 |
Cytimmune Sciences, Inc. |
Method and compositions for enhancing immune response and for the production of in vitro mabs
|
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
|
DK1074268T3
(da)
|
1998-03-17 |
2008-04-28 |
Chugai Pharmaceutical Co Ltd |
IL-6-receptorantagonistantistofholdige forebyggende eller terapeutiske midler mod inflammatoriske tarmsygdomme
|
|
WO1999055369A1
(en)
|
1998-04-28 |
1999-11-04 |
Smithkline Beecham Corporation |
Monoclonal antibodies with reduced immunogenicity
|
|
US6620382B1
(en)
|
1998-05-22 |
2003-09-16 |
Biopheresis Technologies, Llc. |
Method and compositions for treatment of cancers
|
|
GB9815909D0
(en)
|
1998-07-21 |
1998-09-16 |
Btg Int Ltd |
Antibody preparation
|
|
US6838290B2
(en)
|
1998-08-21 |
2005-01-04 |
Immunex Corporation |
Methods for screening compounds that affect IL-1 epsilon activity
|
|
US7345217B2
(en)
|
1998-09-22 |
2008-03-18 |
Mendel Biotechnology, Inc. |
Polynucleotides and polypeptides in plants
|
|
EP1115427B1
(de)
|
1998-09-25 |
2003-12-03 |
Horst Lindhofer |
Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
|
|
DE69940383D1
(de)
|
1998-10-21 |
2009-03-19 |
Chugai Pharmaceutical Co Ltd |
Verfahren zum screenen von verbindungen, die die produktion von entzündungszytokinen inhibieren
|
|
US6972125B2
(en)
|
1999-02-12 |
2005-12-06 |
Genetics Institute, Llc |
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
|
|
US6419944B2
(en)
|
1999-02-24 |
2002-07-16 |
Edward L. Tobinick |
Cytokine antagonists for the treatment of localized disorders
|
|
CA2388245C
(en)
|
1999-10-19 |
2012-01-10 |
Kyowa Kirin Co., Ltd. |
The use of serum-free adapted rat cells for producing heterologous polypeptides
|
|
US6342587B1
(en)
|
1999-10-22 |
2002-01-29 |
Ludwig Institute For Cancer Research |
A33 antigen specific immunoglobulin products and uses thereof
|
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
|
AU2001278129A1
(en)
|
2000-07-31 |
2002-02-13 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Specific binding agents for kshv vil-6 that neutralize a biological activity
|
|
EP2351838A1
(en)
|
2000-10-20 |
2011-08-03 |
Chugai Seiyaku Kabushiki Kaisha |
Crosslinking agonistic antibodies
|
|
DE60133029T2
(de)
|
2000-10-25 |
2009-03-12 |
Chugai Seiyaku K.K. |
Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff
|
|
WO2002036164A1
(en)
|
2000-10-27 |
2002-05-10 |
Chugai Seiyaku Kabushiki Kaisha |
Blooe vegf level-lowering agent containing il-6 antagonist as the active ingredient
|
|
WO2002036165A1
(fr)
|
2000-10-27 |
2002-05-10 |
Chugai Seiyaku Kabushiki Kaisha |
Agent à base d'antagoniste d'il-6, faisant baisser le niveau des mmp-3 dans le sang
|
|
IL139380A0
(en)
|
2000-10-31 |
2001-11-25 |
Prochon Biotech Ltd |
Active variants of fibroblast growth factor
|
|
US20040198661A1
(en)
|
2000-12-08 |
2004-10-07 |
Bowdish Katherine S. |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
|
|
US7462694B2
(en)
|
2001-02-02 |
2008-12-09 |
Rutgers, The State University |
C-terminally truncated non-cytotoxic PAP mutants
|
|
US7169573B2
(en)
|
2001-02-20 |
2007-01-30 |
Oklahoma Medical Research Foundation |
Method for monitoring coagulability and hypercoagulable states
|
|
UA80091C2
(en)
|
2001-04-02 |
2007-08-27 |
Chugai Pharmaceutical Co Ltd |
Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
|
|
JP2003066047A
(ja)
|
2001-06-14 |
2003-03-05 |
Matsushita Electric Ind Co Ltd |
免疫反応測定方法及びそれに用いる免疫反応測定用試薬
|
|
EP1414466B1
(en)
|
2001-07-09 |
2009-08-19 |
CombinatoRx, Incorporated |
Combinations for the treatment of inflammatory disorders
|
|
US20030219839A1
(en)
|
2001-09-20 |
2003-11-27 |
Katherine Bowdish |
Anti-PDGF antibodies and methods for producing engineered antibodies
|
|
BRPI0214168B8
(pt)
|
2001-11-14 |
2021-05-25 |
Centocor Inc |
anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
|
|
US20040185040A1
(en)
|
2001-11-21 |
2004-09-23 |
Celltech R & D Limited |
Modulating immune responses
|
|
JP2005519586A
(ja)
|
2001-11-21 |
2005-07-07 |
セルテック アール アンド ディー， インコーポレイテッド |
Ｃｄ８３遺伝子産物を利用したサイトカイン・レベルの操作法
|
|
US7393648B2
(en)
|
2001-12-03 |
2008-07-01 |
Alexion Pharmaceuticals, Inc. |
Hybrid antibodies
|
|
US7282567B2
(en)
|
2002-06-14 |
2007-10-16 |
Immunomedics, Inc. |
Monoclonal antibody hPAM4
|
|
US8188231B2
(en)
|
2002-09-27 |
2012-05-29 |
Xencor, Inc. |
Optimized FC variants
|
|
GB0209884D0
(en)
|
2002-04-30 |
2002-06-05 |
Ares Trading Sa |
Proteins
|
|
US20030229030A1
(en)
|
2002-06-11 |
2003-12-11 |
Theoharides Theoharis C. |
Method of treating interleukin-6-mediated inflammatory diseases
|
|
US20040001831A1
(en)
|
2002-06-26 |
2004-01-01 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders
|
|
AU2003264009A1
(en)
|
2002-08-15 |
2004-03-03 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
US20060078532A1
(en)
|
2004-10-12 |
2006-04-13 |
Omoigui Osemwota S |
Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease
|
|
US20060275294A1
(en)
|
2002-08-22 |
2006-12-07 |
Omoigui Osemwota S |
Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer
|
|
US20060078533A1
(en)
|
2004-10-12 |
2006-04-13 |
Omoigui Osemwota S |
Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer
|
|
JP4463104B2
(ja)
|
2002-08-30 |
2010-05-12 |
財団法人化学及血清療法研究所 |
ヒト抗ヒトインターロイキン−６抗体及び該抗体フラグメント
|
|
CN101972478B
(zh)
|
2002-10-08 |
2012-10-31 |
免疫医疗公司 |
抗体治疗
|
|
WO2004048552A2
(en)
|
2002-11-21 |
2004-06-10 |
Celltech R & D, Inc. |
Modulating immune responses
|
|
DE60333228D1
(de)
|
2002-12-02 |
2010-08-12 |
Amgen Fremont Inc |
Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen
|
|
JP2007524566A
(ja)
|
2002-12-20 |
2007-08-30 |
エンカム ファーマシューティカルズ アクティーゼルスカブ |
レセプターとリガンドの間の相互作用の調節の方法
|
|
US7534427B2
(en)
|
2002-12-31 |
2009-05-19 |
Immunomedics, Inc. |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
|
|
AU2004212843B2
(en)
|
2003-02-24 |
2009-06-25 |
Chugai Seiyaku Kabushiki Kaisha |
Remedy for spinal injury containing interleukin-6 antagonist
|
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
|
GB0312481D0
(en)
|
2003-05-30 |
2003-07-09 |
Celltech R&D Ltd |
Antibodies
|
|
AU2004255553B2
(en)
|
2003-06-19 |
2009-08-20 |
Genentech, Inc. |
Compositions and methods for treating coagulation related disorders
|
|
US20050048578A1
(en)
|
2003-06-26 |
2005-03-03 |
Epitomics, Inc. |
Methods of screening for monoclonal antibodies with desirable activity
|
|
US20060210563A1
(en)
|
2003-07-25 |
2006-09-21 |
Juan Lopez De Silanes |
Administration of anti-cytokine f(ab')2 antibody fragments
|
|
EP1651659A4
(en)
|
2003-08-07 |
2008-09-17 |
Epitomics Inc |
METHOD FOR HUMANIZATION OF MONOCLONAL RABBIT ANTIBODIES
|
|
WO2005037314A1
(en)
|
2003-08-20 |
2005-04-28 |
Centocor, Inc. |
Method for generating antibodies
|
|
CN1871259A
(zh)
|
2003-08-22 |
2006-11-29 |
比奥根艾迪克Ma公司 |
具有改变的效应物功能的经改进的抗体和制备它的方法
|
|
EP1664774A4
(en)
|
2003-08-29 |
2007-06-27 |
Centocor Inc |
RAPID MEANS FOR OBTAINING HIGH-EXPRESSION CLONES OF MAMMALIAN CELLS, ACCORDING TO A METHYLCELLULOSE SCREENING METHOD AND IMMUNOPRECIPITATION
|
|
US7392140B2
(en)
|
2003-09-23 |
2008-06-24 |
Prediction Sciences, Llc |
Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
|
|
US7634360B2
(en)
|
2003-09-23 |
2009-12-15 |
Prediction Sciences, LL |
Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
|
|
KR101193708B1
(ko)
|
2003-10-17 |
2012-10-22 |
추가이 세이야쿠 가부시키가이샤 |
중피종 치료제
|
|
PT1678314E
(pt)
|
2003-10-22 |
2012-11-27 |
Keck Graduate Inst |
Métodos de síntese de polipéptidos heteromultiméricos em levedura utilizando uma estratégia de conjugação haplóide
|
|
US8617550B2
(en)
|
2003-12-19 |
2013-12-31 |
Chugai Seiyaku Kabushiki Kaisha |
Treatment of vasculitis with IL-6 antagonist
|
|
BRPI0512915A
(pt)
|
2004-06-29 |
2008-04-15 |
Warner Lambert Co |
terapias de combinação utilizando inibidores benzamida do receptor p2x7
|
|
DK1781818T3
(en)
|
2004-07-22 |
2017-10-16 |
Early Detection Llc |
Cancer and inflammation diagnosis using sTNFR antibodies
|
|
US20060051348A1
(en)
|
2004-09-09 |
2006-03-09 |
Jorn Gorlach |
Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
|
|
US20070036788A1
(en)
|
2004-09-22 |
2007-02-15 |
Ahmed Sheriff |
Use of a compound for reducing the biological effectiveness of il-6
|
|
US20060121042A1
(en)
|
2004-10-27 |
2006-06-08 |
Medimmune, Inc. |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
|
US7462697B2
(en)
|
2004-11-08 |
2008-12-09 |
Epitomics, Inc. |
Methods for antibody engineering
|
|
US20060171943A1
(en)
|
2005-02-01 |
2006-08-03 |
Amgen Inc. |
Compositions and methods of treating fibrotic disorders
|
|
ITRM20050103A1
(it)
|
2005-03-10 |
2006-09-11 |
Rocco Savino |
Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi.
|
|
US20080033027A1
(en)
|
2005-03-21 |
2008-02-07 |
Vicus Therapeutics Spe 1, Llc |
Drug combination pharmaceutical compositions and methods for using them
|
|
US7431927B2
(en)
|
2005-03-24 |
2008-10-07 |
Epitomics, Inc. |
TNFα-neutralizing antibodies
|
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
|
US20070048306A1
(en)
|
2005-08-30 |
2007-03-01 |
Giles-Komar Jill M |
Method for generating anti-variable region monoclonal antibodies
|
|
WO2008093148A2
(en)
|
2005-12-22 |
2008-08-07 |
Anaborex, Inc. |
Compositions and methods for prevention and treatment of cachexia
|
|
WO2007076927A1
(en)
|
2005-12-30 |
2007-07-12 |
Merck Patent Gmbh |
Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
|
|
US7790463B2
(en)
|
2006-02-02 |
2010-09-07 |
Yale University |
Methods of determining whether a pregnant woman is at risk of developing preeclampsia
|
|
WO2007104529A2
(en)
|
2006-03-13 |
2007-09-20 |
Ablynx N.V. |
Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
|
|
US7504106B2
(en)
|
2006-03-14 |
2009-03-17 |
Boris Skurkovich |
Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis
|
|
US9399061B2
(en)
|
2006-04-10 |
2016-07-26 |
Abbvie Biotechnology Ltd |
Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
|
|
DK2021463T3
(en)
|
2006-05-19 |
2017-01-16 |
Alder Biopharmaceuticals Inc |
Culture method to obtain a cloned population of antigen-specific B cells
|
|
JP2009536641A
(ja)
|
2006-05-31 |
2009-10-15 |
ハンワ ケミカル コーポレイション |
Ｖｃａｍ−１特異的モノクローナル抗体
|
|
ES2398076T3
(es)
|
2006-06-02 |
2013-03-13 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos de alta afinidad contra el receptor de IL-6 humano
|
|
MX2009001110A
(es)
|
2006-08-03 |
2009-05-11 |
Vaccinex Inc |
Anticuerpos monoclonales anti-il-6 y usos de los mismos.
|
|
CA2914170C
(en)
|
2006-09-08 |
2018-10-30 |
Abbvie Bahamas Ltd. |
Interleukin-13 binding proteins
|
|
WO2008042611A2
(en)
*
|
2006-09-29 |
2008-04-10 |
Centocor, Inc. |
Method of using il6 antagonists with mitoxantrone for prostate cancer
|
|
AU2007317333A1
(en)
|
2006-11-02 |
2008-05-15 |
Seattle Genetics, Inc. |
Methods of treating neoplastic, autoimmune and inflammatory diseases
|
|
TW200831528A
(en)
|
2006-11-30 |
2008-08-01 |
Astrazeneca Ab |
Compounds
|
|
JP4652363B2
(ja)
|
2007-03-16 |
2011-03-16 |
本田技研工業株式会社 |
メタル取付装置
|
|
US20090238825A1
(en)
|
2007-05-21 |
2009-09-24 |
Kovacevich Brian R |
Novel rabbit antibody humanization methods and humanized rabbit antibodies
|
|
US7906117B2
(en)
|
2007-05-21 |
2011-03-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
|
|
KR20170036814A
(ko)
|
2007-05-21 |
2017-04-03 |
앨더바이오 홀딩스 엘엘씨 |
신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
|
|
US8062864B2
(en)
|
2007-05-21 |
2011-11-22 |
Alderbio Holdings Llc |
Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
|
|
US8178101B2
(en)
|
2007-05-21 |
2012-05-15 |
Alderbio Holdings Inc. |
Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
|
|
US8252286B2
(en)
|
2007-05-21 |
2012-08-28 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
US9701747B2
(en)
|
2007-05-21 |
2017-07-11 |
Alderbio Holdings Llc |
Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
|
|
HUE032563T2
(en)
*
|
2007-05-21 |
2017-09-28 |
Alderbio Holdings Llc |
Antibodies to IL-6 and their use
|
|
US8404235B2
(en)
|
2007-05-21 |
2013-03-26 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
WO2008156807A2
(en)
|
2007-06-19 |
2008-12-24 |
The Johns Hopkins University |
Antithrombotic agents and methods of use thereof
|
|
US8277804B2
(en)
|
2008-05-21 |
2012-10-02 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
CA2742786A1
(en)
|
2008-11-13 |
2010-05-20 |
Femta Pharmaceuticals, Inc. |
Humanized anti-il-6 antibodies
|
|
US8337847B2
(en)
|
2008-11-25 |
2012-12-25 |
Alderbio Holdings Llc |
Methods of treating anemia using anti-IL-6 antibodies
|
|
US9212223B2
(en)
|
2008-11-25 |
2015-12-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
CA2744400C
(en)
*
|
2008-11-25 |
2019-01-15 |
Alder Biopharmaceuticals, Inc. |
Antibodies to il-6 and use thereof
|
|
US8420089B2
(en)
|
2008-11-25 |
2013-04-16 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
US9452227B2
(en)
|
2008-11-25 |
2016-09-27 |
Alderbio Holdings Llc |
Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
|
|
US8323649B2
(en)
|
2008-11-25 |
2012-12-04 |
Alderbio Holdings Llc |
Antibodies to IL-6 and use thereof
|
|
US8992920B2
(en)
|
2008-11-25 |
2015-03-31 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of arthritis
|
|
CA2765220A1
(en)
|
2009-07-14 |
2011-01-20 |
Biogen Idec Ma Inc. |
Methods for inhibiting yellow color and peroxide formation in a composition
|
|
WO2011066374A2
(en)
*
|
2009-11-24 |
2011-06-03 |
Alder Biopharmaceuticals, Inc. |
Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
|
|
US9775921B2
(en)
|
2009-11-24 |
2017-10-03 |
Alderbio Holdings Llc |
Subcutaneously administrable composition containing anti-IL-6 antibody
|
|
US9304134B2
(en)
|
2010-11-23 |
2016-04-05 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of anemia
|
|
WO2015054293A1
(en)
|
2013-10-07 |
2015-04-16 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of psoriatic arthritis
|